PRICE T ROWE ASSOCIATES INC /MD/

Position in ALXO — Alx Oncology Holdings Inc

CIK 80255 BALTIMORE, MD

Position in ALXO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$185,842

+$179,225 QoQ

Shares Held

89,779

+745.2% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 94 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. ALXO ranks #256 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$185,842	89,779	+745.2%	Shares	Defined	2026-08-14
2025-03-31	$6,617	10,622	0.0%	Shares	Defined	2025-05-14
2024-12-31	$17,738	10,622	0.0%	Shares	Defined	2025-02-14
2024-09-30	$19,332	10,622	0.0%	Shares	Defined	2024-11-14
2024-06-30	$64,050	10,622	-95.4%	Shares	Defined	2024-08-14
2024-03-31	$2,595,374	232,769	-57.2%	Shares	Sole	2024-05-15
2023-12-31	$8,088,887	543,243	+13117.6%	Shares	Sole	2024-02-16
2021-09-30	$303,564	4,110	+1.1%	Shares	Sole	2021-11-15
2021-06-30	$222,328	4,066	-9.1%	Shares	Sole	2021-08-16
2021-03-31	$329,912	4,474	-98.0%	Shares	Sole	2021-05-17
2020-09-30	$8,440,701	223,654	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.